In humans, phosphorylated ubiquitin signaling as a downstream of the PINK1-Parkin pathway was elevated in the substantia nigra dopaminergic neurons of sporadic PD patients, whereas this was not evident in those of PARK2 PD patients (Shiba-Fukushima et al., 2017). Here, PRKN is linked to Parkinson disease.